 Jul.29 -- Christian Hogg, chief executive officer at Hutchmed, a cancer drug developer, discusses Chinas regulatory crackdown, doing business in China and the outlook for the biotech sector. He speaks exclusively on Bloomberg Daybreak: Asia. 